Enhanced expression of MMP7 in MMTV-Ron VDR−/− mammary tumors and, conversely, reduced expression in R7 cells treated with 1,25D3 suggests a mechanism by which ligand-dependent VDR signaling delays tumor formation and mitigates progression. This evidence concerns the gene MMP7 and breast cancer.